Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,473 | 5,230 | 6,686 | 8,289 | 8,455 |
| Receivables | N/A | N/A | N/A | 635 | N/A |
| TOTAL | $4,901 | $5,947 | $7,560 | $10,001 | $8,899 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 101 | 101 | 101 | 100 | 2 |
| TOTAL | $101 | $101 | $101 | $100 | $2 |
| Total Assets | $5,002 | $6,048 | $7,661 | $10,101 | $8,901 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 434 | 202 | 744 | 1,275 | 296 |
| Accrued Expenses | 164 | 145 | 231 | 391 | 618 |
| TOTAL | $598 | $347 | $975 | $1,666 | $914 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 151,049 | 151,049 | 151,049 | 152,104 | 151,049 |
| TOTAL | $151,049 | $151,049 | $151,049 | $152,104 | $151,049 |
| Total Liabilities | $151,647 | $151,396 | $152,024 | $153,770 | $151,963 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,462 | 75,462 | 75,462 | 75,462 | 54,392 |
| Common Shares | 75 | 75 | 75 | 75 | 54 |
| Retained earnings | -460,418 | -459,030 | -457,955 | -456,363 | -451,432 |
| Other shareholders' equity | 2,577 | 2,597 | 2,864 | 4,372 | 0 |
| TOTAL | $-146,645 | $-145,348 | $-144,363 | $-143,669 | $-143,062 |
| Total Liabilities And Equity | $5,002 | $6,048 | $7,661 | $10,101 | $8,901 |